Back to search
Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID) trials you may qualify forThe aim of this study is to assess the safety and efficacy of autologous transplantation of hematopoietic stem cells (CD34+ cells) from mobilized peripheral blo…
This is a Phase I/II trial of in vivo lentiviral gene therapy for treating adenosine deaminase severe combined immunodeficiency (ADA-SCID) using a self-inactiva…
This observational long-term follow-up study is designed to collect safety and efficacy data from ADA-SCID patients previously treated with autologous ex vivo g…
Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approa…